Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
about
Pathogenesis of myasthenia gravis: update on disease types, models, and mechanismsAnimal models of myasthenia gravis: utility and limitationsCollagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravisThe mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure.Postnatal Development of Spasticity Following Transgene Insertion in the Mouse βIV Spectrin Gene (SPTBN4).
P2860
Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
@en
type
label
Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
@en
prefLabel
Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
@en
P2093
P50
P1476
Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis
@en
P2093
K Shigemoto
P Christadoss
P356
10.1016/J.EXPNEUROL.2014.12.013
P407
P577
2014-12-24T00:00:00Z